Loading...

An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC)

We report a case using combination cabozantinib plus nivolumab to salvage disease control in a patient with refractory metastatic renal cell carcinoma. The patient had previously experienced disease progression from high‐dose interleukin‐2, sunitinib, pazopanib, cabozantinib, and nivolumab, all give...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Kao, Chester, George, Daniel J., Zhang, Tian
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930408/
https://ncbi.nlm.nih.gov/pubmed/33251710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13617
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!